These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7111359)

  • 1. Characteristics of monoamine oxidase activity in mouse brain.
    Hall TR; Figueroa HR
    Pharmacol Res Commun; 1982 May; 14(5):431-41. PubMed ID: 7111359
    [No Abstract]   [Full Text] [Related]  

  • 2. Modification of brain mitochondrial monoamine oxidase activities by hydroxyethylhydrazide of cyanoacetic acid and some other monoamine oxidase inhibitors.
    Baumanis EA; Kalnina IE; Moskvitina TA; Gorkin VZ
    Biochem Pharmacol; 1977 Jun; 26(11):1059-63. PubMed ID: 18152
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of inhibitors on monoamine oxidase activity in mouse brain.
    Hall TR; Figueroa HR; Yurgens PB
    Pharmacol Res Commun; 1982 May; 14(5):443-53. PubMed ID: 6810387
    [No Abstract]   [Full Text] [Related]  

  • 4. Inhibitory effects of ethaverine, a homologue of papaverine, on monoamine oxidase activity in mouse brain.
    Lee SS; Lee JJ; Cheong MJ; Kim YH; Kim Y; Yun YP; Lee CK; Lee MK
    Biol Pharm Bull; 2001 Jul; 24(7):838-40. PubMed ID: 11456127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro inhibition of brain mitochondrial monoamine oxidase by 6-hydroxydopamine.
    Youdim MB
    Br J Pharmacol; 1975 Jul; 54(3):403-5. PubMed ID: 1164597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of monoamine oxidase by palmatine.
    Lee SS; Kim YH; Lee MK
    Arch Pharm Res; 1999 Oct; 22(5):529-31. PubMed ID: 10549584
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of aluminium (Al) on brain mitochondrial monoamine oxidase-A (MAO-A) activity--an in vitro kinetic study.
    Rao KS; Rao GV
    Mol Cell Biochem; 1994 Aug; 137(1):57-60. PubMed ID: 7845378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deamination of dopamine and its 3-O-methylated derivative by human brain monoamine oxidase.
    Roth JA; Feor K
    Biochem Pharmacol; 1978; 27(11):1606-8. PubMed ID: 697902
    [No Abstract]   [Full Text] [Related]  

  • 9. Further studies on the inhibition of monoamine oxidation by monoamine oxidase inhibitors.
    Ghosh SK; Guha SR
    Biochem Pharmacol; 1978 Jan; 27(1):112-4. PubMed ID: 619893
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of type A monoamine oxidase by coptisine in mouse brain.
    Ro JS; Lee SS; Lee KS; Lee MK
    Life Sci; 2001 Dec; 70(6):639-45. PubMed ID: 11833714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoamine oxidase activity and monoamine metabolism in brains of parkinsonian patients treated with l-deprenyl.
    Riederer P; Youdim MB
    J Neurochem; 1986 May; 46(5):1359-65. PubMed ID: 2420928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoamine oxidase: examination of multiple forms.
    Jain M
    Life Sci; 1977 Jun; 20(12):1925-33. PubMed ID: 329033
    [No Abstract]   [Full Text] [Related]  

  • 13. Some parameters affecting the activity of monoamine oxidase in purified bovine brain mitochondria.
    Gabay S; Achee FM; Mentes G
    J Neurochem; 1976 Aug; 27(2):415-24. PubMed ID: 9476
    [No Abstract]   [Full Text] [Related]  

  • 14. Biogenic amine metabolism in Biomphalaria glabrata-II. Monoamine oxidase activity.
    Mermel L; Guchhait RB; Bourgeois JG; Bueding E
    Comp Biochem Physiol C Comp Pharmacol; 1981; 69(2):227-34. PubMed ID: 6116567
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of type A and B monoamine oxidase by 6,7-dihydroxy-1,2,3,4-tetrahydroisoquinolines and their N-methylated derivatives.
    Minami M; Maruyama W; Dostert P; Nagatsu T; Naoi M
    J Neural Transm Gen Sect; 1993; 92(2-3):125-35. PubMed ID: 8369106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychoactive drug effects and substrate-specificity in intact mitochondrial monoamine oxidase from brain [proceedings].
    Gabay S; Achee FM
    Psychopharmacol Bull; 1977 Jan; 13(1):45-6. PubMed ID: 13452
    [No Abstract]   [Full Text] [Related]  

  • 17. Quinoline and quninaldine as naturally occurring inhibitors specific for type A monoamine oxidase.
    Naoi M; Nagatsu T
    Life Sci; 1987 Mar; 40(11):1075-82. PubMed ID: 3821373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoamine oxidase. I. Specificity of some substrates and inhibitors.
    Williams CH
    Biochem Pharmacol; 1974 Feb; 23(3):615-28. PubMed ID: 4822746
    [No Abstract]   [Full Text] [Related]  

  • 19. Substituted amphetamine derivatives. I. Effect on uptake and release of biogenic monoamines and on monoamine oxidase in the mouse brain.
    Ross SB; Ogren SO; Renyi AL
    Acta Pharmacol Toxicol (Copenh); 1977 Oct; 41(4):337-52. PubMed ID: 579062
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on monoamine oxidase (report XXIV). Effect of harmine on monoamine oxidase.
    Yasuhara H
    Jpn J Pharmacol; 1974 Aug; 24(4):523-33. PubMed ID: 4156374
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.